Global Bipolar Disorder Treatment Market- Market Overview:

The global bipolar disorder treatment market is expected to grow from USD 4.42 billion in 2022 to USD 5.7 billion by 2030, at a CAGR of 3.3% during the Projection period 2023-2030. The growth of this market is mainly driven owing to the rising government initiatives to spread awareness about the proper management of the bipolar disorder.

A chronic mood disorder known as bipolar disorder causes extreme mood swings, fluctuation in energy levels, and behaviour. The main signs of bipolar disorder include manic and hypomanic episodes and depressive episodes. In addition to medications, talk therapy, lifestyle changes, and other treatments, the condition can be managed. According to WHO, bipolar disorder is the 6th biggest contributor to the total number of disabled people in the world. To mitigate its serious consequences, modern medicine has developed therapeutic drugs for its treatment that are now available in drug stores as over-the-counter bipolar medication. An increasing number of regulatory authorities are issuing special designations to boost the market. In addition to rising expenditures on healthcare infrastructure development, growing adoption of sedentary lifestyles increased government initiatives to promote awareness in backward areas, and an upswing in strategic collaboration among market players, other factors are also contributing to the market's growth. It has been observed that when treatment medications are prescribed to pregnant women, some medications can cause serious secondary effects such as renal disappointment and teratogenic changes in the hatchlings. Additionally, a tremendous number of times, bipolar turmoil may be misdiagnosed as depressive symptoms or a behavioural condition, which can likewise cause a delay in the discovery and treatment of this psychological disorder.

Sample Request: - Global Bipolar Disorder Treatment Market

Market Dynamics:

Drivers:                          

• Rising government initiatives

The bipolar disorder treatment market is witnessing immense growth as people are becoming more aware of the management of the disorder due to rising government initiatives to spread awareness about bipolar disorder. In addition to conducting research studies and developing new medications for bipolar disorder drug therapy, scientific organizations and medical institutions also actively participate in the treatment of the bipolar disorder.

Restraints:                                             

• Side effects associated with bipolar disorder treatment medications

Bipolar disorder treatment medications are causing side effects that are hindering the market growth. As a result of increasing awareness among the general population regarding the ill effects of long-term bipolar disorder drug use, as well as increased patient demand for chemical-free bipolar disorder medications, the demand for treatment may be slow over the Projection period.

Opportunities:

• Technological Advancements

Technological advancements in the bipolar disorder treatment market are proven to be a beneficial step in the market growth. Wearable devices which can keep a check on each and every movement of the body and behavioural change are helping patients.

Challenges:

• Lack of trained medical professionals

There will be a major challenge to market growth in developing and underdeveloped economies due to a lack of skilled medical professionals and unfavourable reimbursement situations. The growth of the market will also be hindered by the high costs associated with research and development capabilities.

Segmentation Analysis:

The global bipolar disorder treatment market has been segmented based on drug class, mechanism of action, and region.

By Drug Class

The drug class segment includes antidepressant drugs, mood stabilizers, antipsychotic drugs, antianxiety and others. The antipsychotic drugs segment led the largest share of the bipolar disorder treatment market with a market share of around 29% in 2022. Bipolar disorder treatment market revenue was dominated by antipsychotic drugs. The drug is combined with selective serotonin reuptake inhibitors (SSRI) to form a blend and has been shown to have excellent outcomes, prompting more physicians to prescribe it. As a temporary treatment for bipolar disorder, antipsychotic drugs are used to control insane side effects like hallucinations, and mania symptoms.

By Mechanism of Action

The mechanism of the action segment includes beta-blockers, selective serotonin reuptake inhibitors, tricyclic antidepressant drugs and others. The selective serotonin reuptake inhibitors segment led the largest share of the bipolar disorder treatment market with a market share of around 31% in 2022. An important reason for depression is insufficient serotonin, one of the major reasons for SSRIs' helpful actions. SSRIs work by inhibiting serotonin reuptake and thereby developing serotonin action as a result. As a result of their fewer effects on adrenergic, cholinergic, and histaminergic receptors, SSRIs also have moderately fewer aftereffects than other drugs.

Global Bipolar Disorder Treatment Market- Sales Analysis.

The sale of bipolar disorder treatment expanded at a CAGR of 3.1% from 2016 to 2022.

Several factors are driving the market for bipolar disorder treatment, including an increasing prevalence and innovation that works with exact recognition of the mental state and mind of a patient. A decrease in the use of tricyclic antidepressants has been attributed, for example, to a higher number of secondary effects compared to different medications used to treat the disorder.

In addition to improving the market for bipolar disorder drugs and treatment, technological advancements make it easier to detect a patient's emotional and mental state, as well as collect physiological, behavioural, and environmental information effectively, with the help of wearable devices.

The introduction of online self-management tools for mental illnesses has also helped bipolar disorder sufferers to get treatment earlier and better adhere to their medication regimens.

Thus, owing to the aforementioned factors, the global bipolar disorder treatment market is expected to grow at a CAGR of 9.6% during the Projection period from 2023 to 2030.

By Regional Analysis:

The regions analyzed for the bipolar disorder treatment market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. The North American region dominated the bipolar disorder treatment market and held a 37.8% share of the market revenue in 2022.

• The North American region witnessed a major share. As a result of the high level of anxiety, lack of rest, and pattern of substance abuse among the population, North America is expected to experience the highest growth in the bipolar disorder treatment market during the Projection period. As well as to support patients with bipolar disorder, government initiatives to promote mindfulness and support will boost the market growth.
• Asia Pacific is anticipated to experience significant growth during the predicted period. Asia Pacific is expected to enrol a higher CAGR over the Projectioned period because mental problems are more prevalent here. Among the nations most affected by mental disorders like schizophrenia, bipolar disorder, and tension, India and China rank among the highest.

Global Bipolar Disorder Treatment Market - Country Analysis:

• Germany

Germany's bipolar disorder treatment market size was valued at USD 0.33 billion in 2022 and is expected to reach USD 0.43 billion by 2030, at a CAGR of 3.4% from 2023 to 2030.

The growth of the bipolar disorder market is fueled by technological advancements that have been used to develop genetic research and further expand the market, growing awareness of the disorder, and mergers & acquisitions among drug manufacturers, propelling the market growth.

• China

China’s bipolar disorder treatment market size was valued at USD 0.34 billion in 2022 and is expected to reach USD 0.45 billion by 2030, at a CAGR of 3.6% from 2023 to 2030.

In addition to increasing expenditure on healthcare infrastructure development, increased government initiatives to boost awareness in underserved areas, and an increase in strategic collaboration among market players, market growth is driven by these factors. Society's increasing acceptance of mental illness is another variable that could provide profitable growth potential for bipolar disorder treatment.

• India

India's bipolar disorder treatment market size was valued at USD 0.26 billion in 2022 and is expected to reach USD 0.34 billion by 2030, at a CAGR of 3.5% from 2023 to 2030.

In India, as a result of a growing geriatric population, increasing knowledge of mental illness, and an increasing number of research and development activities, healthcare infrastructure expenditures are on the rise. Moreover, by conducting research studies and developing new drugs for bipolar disorder treatment, scientific organizations and medical institutions are also actively involved in treating bipolar disorder, which is boosting market growth.

Key Industry Players Analysis:  

To increase their market position in the global bipolar disorder treatment market business, top companies focus on tactics such as adopting new technology, mergers & acquisitions, product developments, collaborations, partnerships, joint ventures, etc.

• GlaxoSmithKline plc
• Johnson & Johnson
• Takeda Pharmaceutical Company Limited
• Allergan plc
• Pfizer Inc.
• Janssen Pharmaceuticals
• Minerva Neurosciences
• Otsuka Holdings Co. Ltd.
• Sumitomo Dainippon Pharma Co. Ltd.
• Novartis AG

Latest Development:

• In January 2022, Oligomannate, Green Valley's novel medication, got FDA endorsement on its IND application for the worldwide multi-focus stage II clinical trial.
• In October 2021, Boryung Pharmaceutical acquired all local rights, including sales and licensing, for Lilly's Zyprexa, a treatment for bipolar disorder.

Report Metrics

Report Attribute	Details
Study Period	2022-2030
Base year	2022
CAGR (%)	3.3%
Market Size	4.42 billion in 2022
Projection period	2023-2030
Projection unit	Value (USD)
Segments covered	By Drug Class, By Mechanism of Action, and By Region.
Report Scope	Revenue Projection, competitive landscape, company ranking, growth factors, and trends
Companies covered	GlaxoSmithKline plc, Johnson & Johnson, Takeda Pharmaceutical Company Limited, Allergan plc, Pfizer Inc., Janssen Pharmaceuticals, Minerva Neurosciences, Otsuka Holdings Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., and Novartis AG.
By Drug Class	Antidepressant Drugs Mood Stabilizers Antipsychotic Drugs Antianxiety Others
By Mechanism of Action	Beta-Blockers Selective Serotonin Reuptake Inhibitors Tricyclic Antidepressant Drugs Others
Regional scope	North America Europe Asia-Pacific South America Middle East and Africa

Scope of the Report

Global Bipolar Disorder Treatment Market by Drug Class:

• Antidepressant Drugs
• Mood Stabilizers
• Antipsychotic Drugs
• Antianxiety
• Others

Global Bipolar Disorder Treatment Market by Mechanism of Action:

• Beta-Blockers
• Selective Serotonin Reuptake Inhibitors
• Tricyclic Antidepressant Drugs
• Others

Global Bipolar Disorder Treatment Market by Region:

• North America
  • USA
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
• Asia-Pacific
  • Japan
  • China
  • India
  • Korea
  • Southeast Asia
• South America
  • Brazil
  • Peru
• Middle East and Africa
  • UAE
  • South Africa
  • Saudi Arabia

Political Factors- Political stability is necessary for business organizations because it influences consumer and investor trust, which greatly impacts the economy. Political turmoil to a high degree has a negative impact on consumer spending, business investment, and economic growth. The region where the bipolar disorder treatment  market is active is currently experiencing some political instability as a result of internal and external conflicts. If management is unable to comprehend and control the current political instability, the company may not be able to achieve its growth objectives, and it might be reluctant to spend more money.

Economic Factors- Strong positive correlation between financial market efficiency and overall economic growth allows for capital accumulation and the production of goods and services. The bipolar disorder treatment   market must choose countries with highly efficient financial needs so that it can quickly assemble financial and human capital. By monitoring the effectiveness of the financial market, the bipolar disorder treatment   market may be able to stay one step ahead of the competition. The bipolar disorder treatment   market should take into account the rates of economic growth of the various countries when considering whether to expand abroad. In countries with strong rates of economic growth, there are more possibilities for pursuing long-term growth objectives. When the economy is expanding slowly, consumer spending becomes more conservative, which directly affects the revenue growth of the bipolar disorder treatment   market.

Social factors- Economic problems and consumption trends are closely intertwined. When consumers have more discretionary income and are eager to spend more on goods and services to improve their lifestyles, the bipolar disorder treatment   market enjoys exciting growth potential. This is due to the ease with which new goods and services may be introduced to these clients, as well as the increased likelihood of revenue growth. To adjust its marketing mix strategies, the bipolar disorder treatment   market must closely evaluate the consumption/spending patterns and preferences of today's increasingly discerning consumers.

Technological Factors- The market and industry as a whole may be affected by the speed and advancement of technical innovation. By studying the forthcoming trends in technological innovation, the bipolar disorder treatment   market will be able to comprehend the rate of new product development, the length of the product life cycle, and the distinctive features that consumers select. By studying consumer attitudes about cutting-edge, new digital technology, the bipolar disorder treatment   market can assess whether moving to e-commerce will be more advantageous than opening a physical site. If competitors use automation technology to reduce costs, the bipolar disorder treatment   market may be driven to convert from manual to automated procedures, particularly if the general public is technologically literate.

Environmental Factors- Due to stringent environmental legislation in many different nations, businesses are under pressure to reduce environmental impact. Because failure to do so could lead to harsh, reputation-damaging criticism from relevant stakeholders, the bipolar disorder treatment   market should adopt ethical production practices in response, encourage ethical consumption among its target market, work to improve its brand's sustainability reputation, and ensure full compliance with local and international environmental laws. The market for flame-resistant fabric must make preparations in order to adhere to regulations and requirements in the Basic Materials sector.

Legal Factors- Employment law refers to a large area of laws that defend workers' rights, including those to a fair wage, equality, equity, inclusion, fairness, and their bodily and emotional safety. In some countries, employment laws are not effectively enforced, while in others, breaching any of the outlined employee rights is punishable by heavy fines. While entering or operating in these countries, the bipolar disorder treatment   market should ensure the security of the working environment. Both direct and indirect discrimination must be prevented, thus the right processes must be in place.

1. Introduction
   • 1. Objectives of the Study
   • 2. Market Definition
   • 3. Research Scope
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
   • 1. Porter’s Five Forces Analysis
   • 2. Value Chain Analysis
   • 3. Top Investment Pockets
     • 3.1. Market Attractiveness Analysis By Drug Class
     • 3.2. Market Attractiveness Analysis By Mechanism of Action
     • 3.3. Market Attractiveness Analysis By Region
   • 4. Industry Trends
5. Market Dynamics
   • 1. Market Evaluation
   • 2. Drivers
     • 2.1. Rising government initiatives
   • 3. Restraints
     • 3.1. Side effects associated with bipolar disorder treatment medications
   • 4. Opportunities
     • 4.1. Technological Advancements
   • 5. Challenges
     • 5.1. Lack of trained medical professionals

6. Global Bipolar Disorder Treatment Market Analysis and Projection, By Drug Class
   • 1. Segment Overview
   • 2. Antidepressant Drugs
   • 3. Mood Stabilizers
   • 4. Antipsychotic Drugs
   • 5. Antianxiety
   • 6. Others
7. Global Bipolar Disorder Treatment Market Analysis and Projection, By Mechanism of Action
   • 1. Segment Overview
   • 2. Beta-Blockers
   • 3. Selective Serotonin Reuptake Inhibitors
   • 4. Tricyclic Antidepressant Drugs
   • 5. Others
8. Global Bipolar Disorder Treatment Market Analysis and Projection, By Regional Analysis
   • 1. Segment Overview
   • 2. North America
     • 2.1. U.S.
     • 2.2. Canada
     • 2.3. Mexico
   • 3. Europe
     • 3.1. Germany
     • 3.2. France
     • 3.3. U.K.
     • 3.4. Italy
     • 3.5. Spain
   • 4. Asia-Pacific
     • 4.1. Japan
     • 4.2. China
     • 4.3. India
   • 5. South America
     • 5.1. Brazil
   • 6. Middle East and Africa
     • 6.1. UAE
     • 6.2. South Africa

9. Global Bipolar Disorder Treatment Market-Competitive Landscape
   • 1. Overview
   • 2. Market Share of Key Players in the Bipolar Disorder Treatment Market
     • 2.1. Global Company Market Share
     • 2.2. North America Company Market Share
     • 2.3. Europe Company Market Share
     • 2.4. APAC Company Market Share
   • 3. Competitive Situations and Trends
     • 3.1. Technology Launches and Developments
     • 3.2. Partnerships, Collaborations, and Agreements
     • 3.3. Mergers & Acquisitions
     • 3.4. Expansions

10. Company Profiles
    • GlaxoSmithKline plc
      • 1.1. Business Overview
      • 1.2. Company Snapshot
      • 1.3. Company Market Share Analysis
      • 1.4. Company Technology Portfolio
      • 1.5. Recent Developments
      • 1.6. SWOT Analysis
    • Johnson & Johnson
      • 2.1. Business Overview
      • 2.2. Company Snapshot
      • 2.3. Company Market Share Analysis
      • 2.4. Company Technology Portfolio
      • 2.5. Recent Developments
      • 2.6. SWOT Analysis
    • Takeda Pharmaceutical Company Limited
      • 3.1. Business Overview
      • 3.2. Company Snapshot
      • 3.3. Company Market Share Analysis
      • 3.4. Company Technology Portfolio
      • 3.5. Recent Developments
      • 3.6. SWOT Analysis
    • Allergan plc
      • 4.1. Business Overview
      • 4.2. Company Snapshot
      • 4.3. Company Market Share Analysis
      • 4.4. Company Technology Portfolio
      • 4.5. Recent Developments
      • 4.6. SWOT Analysis
    • Pfizer Inc.
      • 5.1. Business Overview
      • 5.2. Company Snapshot
      • 5.3. Company Market Share Analysis
      • 5.4. Company Technology Portfolio
      • 5.5. Recent Developments
      • 5.6. SWOT Analysis
    • Janssen Pharmaceuticals
      • 6.1. Business Overview
      • 6.2. Company Snapshot
      • 6.3. Company Market Share Analysis
      • 6.4. Company Technology Portfolio
      • 6.5. Recent Developments
      • 6.6. SWOT Analysis
    • Minerva Neurosciences
      • 7.1. Business Overview
      • 7.2. Company Snapshot
      • 7.3. Company Market Share Analysis
      • 7.4. Company Technology Portfolio
      • 7.5. Recent Developments
      • 7.6. SWOT Analysis
    • Otsuka Holdings Co. Ltd.
      • 8.1. Business Overview
      • 8.2. Company Snapshot
      • 8.3. Company Market Share Analysis
      • 8.4. Company Technology Portfolio
      • 8.5. Recent Developments
      • 8.6. SWOT Analysis
    • Sumitomo Dainippon Pharma Co. Ltd.
      • 9.1. Business Overview
      • 9.2. Company Snapshot
      • 9.3. Company Market Share Analysis
      • 9.4. Company Technology Portfolio
      • 9.5. Recent Developments
      • 9.6. SWOT Analysis
    • Novartis AG
      • Business Overview
      • Company Snapshot
      • Company Market Share Analysis
      • Company Technology Portfolio
      • Recent Developments
      • SWOT Analysis

List of Table

1. Global Bipolar Disorder Treatment Market, By Drug Class, 2023–2030 (USD Billion)
2. Global Antidepressant Drugs, Bipolar Disorder Treatment Market, By Region, 2023–2030 (USD Billion)
3. Global Mood Stabilizers, Bipolar Disorder Treatment Market, By Region, 2023–2030 (USD Billion)
4. Global Antipsychotic Drugs, Bipolar Disorder Treatment Market, By Region, 2023–2030 (USD Billion)
5. Global Antianxiety, Bipolar Disorder Treatment Market, By Region, 2023–2030 (USD Billion)
6. Global Others, Bipolar Disorder Treatment Market, By Region, 2023–2030 (USD Billion)
7. Global Bipolar Disorder Treatment Market, By Mechanism of Action, 2023–2030 (USD Billion)
8. Global Beta-Blockers, Bipolar Disorder Treatment Market, By Region, 2023–2030 (USD Billion)
9. Global Selective Serotonin Reuptake Inhibitors, Bipolar Disorder Treatment Market, By Region, 2023–2030 (USD Billion)
10. Global Tricyclic Antidepressant Drugs, Bipolar Disorder Treatment Market, By Region, 2023–2030 (USD Billion)
11. Global Others, Bipolar Disorder Treatment Market, By Region, 2023–2030 (USD Billion)
12. Global Bipolar Disorder Treatment Market, By Region, 2023–2030 (USD Billion)
13. North America Bipolar Disorder Treatment Market, By Drug Class, 2023–2030 (USD Billion)
14. North America Bipolar Disorder Treatment Market, By Mechanism of Action, 2023–2030 (USD Billion)
15. USA Bipolar Disorder Treatment Market, By Drug Class, 2023–2030 (USD Billion)
16. USA Bipolar Disorder Treatment Market, By Mechanism of Action, 2023–2030 (USD Billion)
17. Canada Bipolar Disorder Treatment Market, By Drug Class, 2023–2030 (USD Billion)
18. Canada Bipolar Disorder Treatment Market, By Mechanism of Action, 2023–2030 (USD Billion)
19. Mexico Bipolar Disorder Treatment Market, By Drug Class, 2023–2030 (USD Billion)
20. Mexico Bipolar Disorder Treatment Market, By Mechanism of Action, 2023–2030 (USD Billion)
21. Europe Bipolar Disorder Treatment Market, By Drug Class, 2023–2030 (USD Billion)
22. Europe Bipolar Disorder Treatment Market, By Mechanism of Action, 2023–2030 (USD Billion)
23. Germany Bipolar Disorder Treatment Market, By Drug Class, 2023–2030 (USD Billion)
24. Germany Bipolar Disorder Treatment Market, By Mechanism of Action, 2023–2030 (USD Billion)
25. France Bipolar Disorder Treatment Market, By Drug Class, 2023–2030 (USD Billion)
26. France Bipolar Disorder Treatment Market, By Mechanism of Action, 2023–2030 (USD Billion)
27. UK Bipolar Disorder Treatment Market, By Drug Class, 2023–2030 (USD Billion)
28. UK Bipolar Disorder Treatment Market, By Mechanism of Action, 2023–2030 (USD Billion)
29. Italy Bipolar Disorder Treatment Market, By Drug Class, 2023–2030 (USD Billion)
30. Italy Bipolar Disorder Treatment Market, By Mechanism of Action, 2023–2030 (USD Billion)
31. Spain Bipolar Disorder Treatment Market, By Drug Class, 2023–2030 (USD Billion)
32. Spain Bipolar Disorder Treatment Market, By Mechanism of Action, 2023–2030 (USD Billion)
33. Asia Pacific Bipolar Disorder Treatment Market, By Drug Class, 2023–2030 (USD Billion)
34. Asia Pacific Bipolar Disorder Treatment Market, By Mechanism of Action, 2023–2030 (USD Billion)
35. Japan Bipolar Disorder Treatment Market, By Drug Class, 2023–2030 (USD Billion)
36. Japan Bipolar Disorder Treatment Market, By Mechanism of Action, 2023–2030 (USD Billion)
37. China Bipolar Disorder Treatment Market, By Drug Class, 2023–2030 (USD Billion)
38. China Bipolar Disorder Treatment Market, By Mechanism of Action, 2023–2030 (USD Billion)
39. India Bipolar Disorder Treatment Market, By Drug Class, 2023–2030 (USD Billion)
40. India Bipolar Disorder Treatment Market, By Mechanism of Action, 2023–2030 (USD Billion)
41. South America Bipolar Disorder Treatment Market, By Drug Class, 2023–2030 (USD Billion)
42. South America Bipolar Disorder Treatment Market, By Mechanism of Action, 2023–2030 (USD Billion)
43. Brazil Bipolar Disorder Treatment Market, By Drug Class, 2023–2030 (USD Billion)
44. Brazil Bipolar Disorder Treatment Market, By Mechanism of Action, 2023–2030 (USD Billion)
45. Middle East and Africa Bipolar Disorder Treatment Market, By Drug Class, 2023–2030 (USD Billion)
46. Middle East and Africa Bipolar Disorder Treatment Market, By Mechanism of Action, 2023–2030 (USD Billion)
47. UAE Bipolar Disorder Treatment Market, By Drug Class, 2023–2030 (USD Billion)
48. UAE Bipolar Disorder Treatment Market, By Mechanism of Action, 2023–2030 (USD Billion)
49. South Africa Bipolar Disorder Treatment Market, By Drug Class, 2023–2030 (USD Billion)
50. South Africa Bipolar Disorder Treatment Market, By Mechanism of Action, 2023–2030 (USD Billion)

List of Figures 

1. Global Bipolar Disorder Treatment Market Segmentation
2. Bipolar Disorder Treatment Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Bipolar Disorder Treatment Market Attractiveness Analysis By Drug Class
9. Global Bipolar Disorder Treatment Market Attractiveness Analysis By Mechanism of Action
10. Global Bipolar Disorder Treatment Market Attractiveness Analysis By Region
11. Global Bipolar Disorder Treatment Market: Dynamics
12. Global Bipolar Disorder Treatment Market Share By Drug Class (2023 & 2030)
13. Global Bipolar Disorder Treatment Market Share By Mechanism of Action (2023 & 2030)
14. Global Bipolar Disorder Treatment Market Share by Regions (2023 & 2030)
15. Global Bipolar Disorder Treatment Market Share by Company (2021)